Explore the detailed record of transactions filed by Liang Peng, Dirigeant. Officer active across 1 companies, notably Clover Biopharmaceuticals, Ltd. - B. Cumulatively, 9 reports have been published. The latest transaction was disclosed on 21 April 2026 (Sale). Regulator: HKEX. The full history is free.
Liang Peng is an executive at Clover Biopharmaceuticals, Ltd. - B, a company specializing in the development of biopharmaceutical products. He plays a key role in the strategic direction of the company, focusing on innovation and research in the biopharmaceutical sector.